Evidence map›Paper›PMID 28754789›Full record

ArticleJournal of the American Society of Nephrology : JASN2017

Sex and Kidney Transplantation: Why Can't a Woman Be More Like a Man?

Phyllis August, Manikkam Suthanthiran

Abstract readEditorialComment
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Phyllis AugustDivision of Nephrology and Hypertension, Departments of Medicine and Transplantation Medicine, NewYork-Presbyterian Weill Cornell, New York, New York paugust@med.cornell.edu.
Manikkam SuthanthiranDivision of Nephrology and Hypertension, Departments of Medicine and Transplantation Medicine, NewYork-Presbyterian Weill Cornell, New York, New York.

Funding

Biomolecular Markers for Safe Minimization of ImmunosuppressionR37AI051652 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SUTHANTHIRAN, MANIKKAM · 2009 to 2021
$4.7M
Clinical utility of extracellular RNA as marker of kidney disease progressionUH3TR000933 · NCATS · ROCKEFELLER UNIVERSITY · PI SUTHANTHIRAN, MANIKKAM, TUSCHL, THOMAS · 2015 to 2017
$2.5M
Clinical utility of extracellular RNA as marker of kidney disease progressionUH2TR000933 · NCATS · ROCKEFELLER UNIVERSITY · PI SUTHANTHIRAN, MANIKKAM, TUSCHL, THOMAS · 2013 to 2014
$988k
NCATS NIH HHS UH2 TR000933NCATS NIH HHS UH3 TR000933NIAID NIH HHS R37 AI051652
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney DiseasesKidney TransplantationFemaleHumansMaleSex Factorsgendertransplantationtransplant outcomes

Identifiers

PMID28754789
PMCPMC5619980

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.